| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1838* | 2021 |
| Combination antifungal therapy for cryptococcal meningitis JN Day, TTH Chau, M Wolbers, PP Mai, NT Dung, NH Mai, NH Phu, ... New England Journal of Medicine 368 (14), 1291-1302, 2013 | 612 | 2013 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 482* | 2021 |
| Adjunctive dexamethasone in HIV-associated cryptococcal meningitis J Beardsley, M Wolbers, FM Kibengo, ABM Ggayi, A Kamali, NTK Cuc, ... New England Journal of Medicine 374 (6), 542-554, 2016 | 323 | 2016 |
| Intensified antituberculosis therapy in adults with tuberculous meningitis AD Heemskerk, ND Bang, NTH Mai, TTH Chau, NH Phu, PP Loc, ... New England Journal of Medicine 374 (2), 124-134, 2016 | 314 | 2016 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... Medrxiv, 2021 | 298 | 2021 |
| Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis NTQ Nhu, D Heemskerk, DDA Thu, TTH Chau, NTH Mai, HDT Nghia, ... Journal of clinical microbiology 52 (1), 226-233, 2014 | 291 | 2014 |
| Salmonella enterica Serovar Paratyphi A and S. enterica Serovar Typhi Cause Indistinguishable Clinical Syndromes in Kathmandu, Nepal AP Maskey, JN Day, PQ Tuan, GE Thwaites, JI Campbell, M Zimmerman, ... Clinical infectious diseases 42 (9), 1247-1253, 2006 | 250 | 2006 |
| Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam T Le, M Wolbers, NH Chi, VM Quang, NT Chinh, NP Huong Lan, PS Lam, ... Clinical Infectious Diseases 52 (7), 945-952, 2011 | 224 | 2011 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 218 | 2022 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 211 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 191 | 2022 |
| Ischemic heart disease after breast cancer radiotherapy JN Day, TTH Chau, DG Lalloo | 174 | 2013 |
| Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal A Loyse, F Dromer, J Day, O Lortholary, TS Harrison Journal of Antimicrobial Chemotherapy 68 (11), 2435-2444, 2013 | 158 | 2013 |
| A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the … TTH Chau, NH Mai, NH Phu, HD Nghia, LV Chuong, DX Sinh, VA Duong, ... BMC infectious diseases 10, 1-8, 2010 | 147 | 2010 |
| A trial of itraconazole or amphotericin B for HIV-associated talaromycosis T Le, NV Kinh, NTK Cuc, NLN Tung, NT Lam, PTT Thuy, DD Cuong, ... New England Journal of Medicine 376 (24), 2329-2340, 2017 | 146 | 2017 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, L Estcourt, L Peto, ... MedRxiv, 2021.03. 09.21252736, 2021 | 142 | 2021 |
| Penicillium marneffei infection in HIV AP Ustianowski, TPM Sieu, JN Day Current opinion in infectious diseases 21 (1), 31-36, 2008 | 119 | 2008 |
| A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults NTH Mai, N Dobbs, NH Phu, RA Colas, LTP Thao, NTT Thuong, ... Elife 7, e33478, 2018 | 112 | 2018 |
| The burden and characteristics of enteric fever at a healthcare facility in a densely populated area of Kathmandu A Karkey, A Arjyal, KL Anders, MF Boni, S Dongol, S Koirala, PVT My, ... PloS one 5 (11), e13988, 2010 | 103 | 2010 |
